In the News

Health literacy can have a significant bearing on outcomes, so helping patients understand their health and treatments is critical.

Davide Garrisi explains how clinical research organizations have created new models and resources to help biotech meet the global demand for innovative new options for patients.

The pandemic’s impact is driving a new consensus that the need is now for expanded use of digitally enabled trials.

Leading life sciences magazine PharmaVoice has named three North Carolina executives to its list of the 100 most inspiring leaders in the pharmaceutical industry.

For any other person, being president of one organization – Evidera – and being the chief medical officer of another – PPD – would be a full-time job. Yet, Karen Kaucic, MD excels in both positions.

The authors discuss how data from migration kinetics studies can be used to develop models that predict levels of leachables and extractables at different temperatures and time points.

Kirsten Messmer and Richard Dennett discuss the development of advanced therapies and the challenges and complexities of getting them through the developmental pathway, which they call “the trip.”

PPD strategically positioned to continue supporting Pfizer in its pursuit of breakthroughs that change patients’ lives.

Under the agreement, PPD to provide drug development services to advance Pfizer’s portfolio.